Overview Fundamentals API Earnings EOD API Sample Code Pricing

Sonnet Biotherapeutics Holdings Inc (SONN NASDAQ) stock market data APIs

$0.84 0.03(3.7%) as of September 13, 2024
Price chart is built with Anychart

Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 that is in Phase 1b/2a clinical trial for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6, which is in Phase 1b/I2a clinical trail to treat chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy; and SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer. It has a license agreement with New Life Therapeutics Pte, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.

Sonnet Biotherapeutics Holdings Inc Financial Data Overview

0.8105
0.84
-
0.84
0.7969
0.6239-3.67
4 217 K
5 203 K
55 881
-0.7
0.991
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SONN',
Type: 'Common Stock',
Name: 'Sonnet Biotherapeutics Holdings Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BVZ4N6',
ISIN: NULL,
CUSIP: NULL,
CIK: '1106838',
EmployerIdNumber: NULL,
FiscalYearEnd: 'September',
IPODate: '2006-10-31',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic Primary',
IsDelisted: false,
}

Sonnet Biotherapeutics Holdings Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 55 881
  • EBITDA -12 263 398
  • Earnings Per Share -0.12
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Sonnet Biotherapeutics Holdings Inc Earnings via APIs

  • Latest Release 2024-08-14
  • EPS/Forecast -0.76

Get Sonnet Biotherapeutics Holdings Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com